These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25584889)

  • 1. Vascular-promoting therapy reduced tumor growth and progression by improving chemotherapy efficacy.
    Bridges E; Harris AL
    Cancer Cell; 2015 Jan; 27(1):7-9. PubMed ID: 25584889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis: a sudden rush of blood to the tumour.
    Villanueva MT
    Nat Rev Cancer; 2015 Mar; 15(3):135. PubMed ID: 25652345
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
    Wong PP; Demircioglu F; Ghazaly E; Alrawashdeh W; Stratford MR; Scudamore CL; Cereser B; Crnogorac-Jurcevic T; McDonald S; Elia G; Hagemann T; Kocher HM; Hodivala-Dilke KM
    Cancer Cell; 2015 Jan; 27(1):123-37. PubMed ID: 25584895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
    Hou JM; Liu JY; Yang L; Zhao X; Tian L; Ding ZY; Wen YJ; Niu T; Xiao F; Lou YY; Tan GH; Deng HX; Li J; Yang JL; Mao YQ; Kan B; Wu Y; Li Q; Wei YQ
    Oncology; 2005; 69(1):81-7. PubMed ID: 16088235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.
    Richards DA
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S9-13. PubMed ID: 16143162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer].
    Ohkawa S
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():198-202. PubMed ID: 16457249
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages.
    Liu Q; Li Y; Niu Z; Zong Y; Wang M; Yao L; Lu Z; Liao Q; Zhao Y
    J Exp Clin Cancer Res; 2016 Feb; 35():33. PubMed ID: 26879926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in pancreatic cancer].
    Láng I
    Orv Hetil; 2004 Feb; 145(5):239-42. PubMed ID: 15024936
    [No Abstract]   [Full Text] [Related]  

  • 10. Putting the chemo in chemoradiation for pancreatic cancer.
    Lowy AM
    Ann Surg Oncol; 2006 Feb; 13(2):135-6. PubMed ID: 16411142
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model.
    Brandes F; Schmidt K; Wagner C; Redekopf J; Schlitt HJ; Geissler EK; Lang SA
    BMC Cancer; 2015 Feb; 15():71. PubMed ID: 25884642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic carcinoma: progress in therapy].
    Lordick F
    Krankenpfl J; 2004; 42(5-6):158-9. PubMed ID: 15527223
    [No Abstract]   [Full Text] [Related]  

  • 13. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.
    García-Santos EP; Padilla-Valverde D; Villarejo-Campos P; Murillo-Lázaro C; Fernández-Grande E; Palomino-Muñoz T; Rodríguez-Martínez M; Amo-Salas M; Nuñez-Guerrero P; Sánchez-García S; Puerto-Puerto A; Martín-Fernández J
    Pancreatology; 2016; 16(4):632-9. PubMed ID: 27289344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IMRD therapy for patients with metastatic pancreas cancer].
    Yamashita K; Takahashi Y
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():219-22. PubMed ID: 16457254
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemcitabine--a major advance?
    Thomas A; Steward WP
    Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.
    Cao Y; Wu L; Tan A; Liu L; Liao C; Gao F
    Pancreas; 2010 Mar; 39(2):253-5. PubMed ID: 20182311
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.
    Quinn BA; Wang S; Barile E; Das SK; Emdad L; Sarkar D; De SK; Morvaridi SK; Stebbins JL; Pandol SJ; Fisher PB; Pellecchia M
    Oncotarget; 2016 Mar; 7(13):17103-10. PubMed ID: 26959746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound and microbubble enhanced treatment of inoperable pancreatic cancer.
    Park K
    J Control Release; 2016 Dec; 243():381. PubMed ID: 28024837
    [No Abstract]   [Full Text] [Related]  

  • 19. Nano-delivery of Gemcitabine Derivative as a Therapeutic Strategy in a Desmoplastic KRAS Mutant Pancreatic Cancer.
    Das M; Li J; Bao M; Huang L
    AAPS J; 2020 Jun; 22(4):88. PubMed ID: 32572645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid.
    Michl P; Gress TM
    Gut; 2012 Oct; 61(10):1377-9. PubMed ID: 22661496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.